Original Research

Published on 03 Nov 2022

Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation

in Cancer Metabolism

Yusuke Aoki
Qinghong Han
Yasunori Tome
Jun Yamamoto
Yutaro Kubota
Noriyuki Masaki
Koya Obara
Kazuyuki Hamada
Justin D. Wang
Sachiko Inubushi

Frontiers in Oncology

doi 10.3389/fonc.2022.1009548

2,828 views
33 citations

Original Research

Published on 31 Oct 2022

Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation

in Cancer Metabolism

Kenza Nedara
Camille Reinhardt
Emilie Lebraud
Giuseppe Arena
Céline Gracia
Valérie Buard
Catherine Pioche-Durieu
Florence Castelli
Benoit Colsch
Paule Bénit

Frontiers in Oncology

doi 10.3389/fonc.2022.958155

4,144 views
3 citations

Mini Review

Published on 31 Oct 2022

Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases

in Cancer Metabolism

Shingo Takada
Shintaro Kinugawa
Haruka Handa
Takashi Yokota
Hisataka Sabe

Frontiers in Oncology

doi 10.3389/fonc.2022.1006322

2,807 views
2 citations

Original Research

Published on 31 Oct 2022

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes

in Cancer Metabolism

Hui-zhong Jiang
Bing Yang
Ya-li Jiang
Xun Liu
Da-lin Chen
Feng-xi Long
Zhu Yang
Dong-xin Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.1025397

2,242 views
3 citations

Original Research

Published on 25 Oct 2022

Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis

in Cancer Metabolism

Ruiqi Jiang
Mingnan Cao
Shenghui Mei
Shanshan Guo
Wei Zhang
Nan Ji
Zhigang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.981406

2,473 views
4 citations

Original Research

Published on 24 Oct 2022

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model

in Cancer Metabolism

Victor Ruiz-Rodado
Tyrone Dowdy
Adrian Lita
Tamalee Kramp
Meili Zhang
Dorela Shuboni-Mulligan
Christel Herold-Mende
Terri S. Armstrong
Mark R. Gilbert
Kevin Camphausen

Frontiers in Oncology

doi 10.3389/fonc.2022.979537

2,344 views

Perspective

Published on 24 Oct 2022

Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal

in Cancer Metabolism

Don Benjamin
Michael N. Hall

Frontiers in Oncology

doi 10.3389/fonc.2022.1034397

4,212 views
6 citations

Original Research

Published on 20 Oct 2022

Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients

in Cancer Metabolism

Zhitao Ye
Yishan Li
Xiaobin Tian
Yan Wei
Yanhui Yu
Kaibin Lai
Keyue Yang
Zixuan Qiu
Jianqing Lin
Meng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1018154

4,562 views
2 citations

Mini Review

Published on 20 Oct 2022

MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma

in Cancer Metabolism

Arianna Romani
Enrico Zauli
Giorgio Zauli
Saleh AlMesfer
Samar Al-Swailem
Rebecca Voltan

Frontiers in Oncology

doi 10.3389/fonc.2022.1000677

2,806 views
6 citations

Original Research

Published on 18 Oct 2022

Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP

in Cancer Metabolism

Anna Moshnikova
Michael DuPont
Hannah Visca
Donald M. Engelman
Oleg A. Andreev
Yana K. Reshetnyak

Frontiers in Oncology

doi 10.3389/fonc.2022.1023959

9,942 views
10 citations

Review

Published on 17 Oct 2022

Glutamine metabolism in cancers: Targeting the oxidative homeostasis

in Cancer Metabolism

Tengfang Gong
Changbing Zheng
Xidan Ou
Jie Zheng
Jiayi Yu
Shuyu Chen
Yehui Duan
Wei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.994672

3,752 views
14 citations

Review

Published on 13 Oct 2022

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease

in Cancer Metabolism

Vincenzo Raimondi
Denise Toscani
Valentina Marchica
Jessica Burroughs-Garcia
Paola Storti
Nicola Giuliani

Frontiers in Oncology

doi 10.3389/fonc.2022.1015402

3,728 views
1 citation

Original Research

Published on 10 Oct 2022

MBTPS1 regulates proliferation of colorectal cancer primarily through its action on sterol regulatory element-binding proteins

in Cancer Metabolism

Liat H. Hartal-Benishay
Esraa Saadi
Shir Toubiana
Lior Shaked
Maya Lalzar
Ossama Abu Hatoum
Sharon Tal
Sara Selig
Liza Barki-Harrington

Frontiers in Oncology

doi 10.3389/fonc.2022.1004014

3,188 views
3 citations

Original Research

Published on 07 Oct 2022

Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy

in Cancer Metabolism

Karen Slattery
Megan Breheny
Elena Woods
Sinead Keating
Kiva Brennan
Caroline Rooney
Sindhu Augustine
Aishling Ryan
Cormac Owens
Clair M. Gardiner

Frontiers in Oncology

doi 10.3389/fonc.2022.1004871

3,721 views
4 citations

Review

Published on 05 Oct 2022

Amino acid metabolism in primary bone sarcomas

in Cancer Metabolism

Jennifer A. Jiménez
Elizabeth R. Lawlor
Costas A. Lyssiotis

Frontiers in Oncology

doi 10.3389/fonc.2022.1001318

4,457 views
5 citations

Review

Published on 05 Oct 2022

Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis

in Cancer Metabolism

Taojian Tu
Mario M. Alba
Aditi A. Datta
Handan Hong
Brittney Hua
Yunyi Jia
Jared Khan
Phillip Nguyen
Xiatoeng Niu
Pranav Pammidimukkala

Frontiers in Oncology

doi 10.3389/fonc.2022.958696

3,378 views
1 citation

Navigation group

Articles

Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation

Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation

Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes

Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model

Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal

Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients

MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma

Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP

Glutamine metabolism in cancers: Targeting the oxidative homeostasis

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease

MBTPS1 regulates proliferation of colorectal cancer primarily through its action on sterol regulatory element-binding proteins

Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy

Amino acid metabolism in primary bone sarcomas

Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis